Earnings Summary

Molecular Templates Inc’s revenue jumped 168.71% since last year same period to $7.02Mn in the Q4 2023. On a quarterly growth basis, Molecular Templates Inc has generated 3.24% jump in its revenue since last 3-months.

Molecular Templates Inc’s net profit jumped 82.09% since last year same period to $-3.95Mn in the Q4 2023. On a quarterly growth basis, Molecular Templates Inc has generated -195.06% fall in its net profits since last 3-months.

Molecular Templates Inc’s net profit margin jumped 93.34% since last year same period to -56.27% in the Q4 2023. On a quarterly growth basis, Molecular Templates Inc has generated -192.08% fall in its net profit margins since last 3-months.

Molecular Templates Inc’s earning per share (EPS) estimates for the current quarter stand at -0.78 - a 19.59% jump from last quarter’s estimates.

Molecular Templates Inc’s earning per share (EPS) estimates for the current year stand at -0.78.

Molecular Templates Inc’s earning per share (EPS) fell -87.18% since last year same period to -0.73 in the Q4 2023. This indicates that the Molecular Templates Inc has generated -87.18% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Molecular Templates Inc’s return on assets (ROA) stands at -0.1.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Molecular Templates Inc’s return on equity (ROE) stands at -4.79.